Activities, Bill Numbers and Titles
|
|
Client: Amgen Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $432.66
|
Senate Bill
|
627
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
2983
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1233
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
652
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
4639
|
An Act establishing the Honorable Peter V. Kocot Act to enhance access to high quality, affordable and transparent healthcare in the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
620
|
An Act relative to health care cost transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3223
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
03/01/2018 |
Charlie Baker
|
Governor
|
$200.00
|
| | Total contributions |
$200.00
|
|